🇺🇸 FDA
Patent

US 12064411

Methods of administering solriamfetol to lactating women

granted A61KA61K31/27A61K9/0053

Quick answer

US patent 12064411 (Methods of administering solriamfetol to lactating women) held by AXSOME MALTA LTD. expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME MALTA LTD.
Grant date
Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/27, A61K9/0053, A61P, A61P43/00